University Hospital Center of Martinique   Report issue

Academic/Hospital Phase 2
Founded: Fort-de-France Martinique

Organization Overview

First Clinical Trial
2016
NCT02338466
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

University Hospital Center of Martinique | University Hospital of Martinique

Active Ingredients

Drugs in Phase 2 Trials (3)

alteplase (Activase) (1 trial)

dinoprostone (prostin e2) (1 trial)

tenecteplase (tnkase) (1 trial)

Drugs in Other Trials (1)

lactobacillus (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infarction, Middle Cerebral Artery (Phase 2)

Nervous System Diseases (Phase 2)

Obstetric Labor Complications (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 4